No Data
No Data
Express News | Jiu'an Healthcare: Net profit in the first quarter fell 58.86% year on year
50 billion! Another college science and technology innovation parent fund established Tianjin University to run out of several unicorns
① Tiankai Jiu'an Haihe Begonia Science and Technology Innovation Parent Fund was officially registered and established, with a scale of 5 billion yuan. In recent years, Tianjin University has continued to make efforts to transform scientific and technological achievements, with an annual funding of 4 billion yuan for scientific research. ② Deep Blue, Yisiwei, and Jingfeng Medical are all proposed IPOs from Tianjin University.
Jiu'an Medical (002432.SZ) has repurchased a total of 5.27% of its shares at a cost of about 1.04 billion yuan
Jiu'an Medical (002432.SZ) issued an announcement. As of April 18, 2024, the company has approved share repurchases...
Jiu'an Medical (002432.SZ): 4.47% of shares have been cumulatively repurchased
Gelonghui, April 12, 丨 Jiu'an Medical (002432.SZ) announced that as of April 12, 2024, the company had repurchased a total of 21,853,761 shares through a special stock repurchase securities account, accounting for 4.47% of the company's total share capital. The highest transaction price was 41.277 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 882,786,470.21 (excluding transaction fees).
Jiu'an Medical (002432.SZ): A total of 3.96% of shares have been repurchased
Gelonghui, April 1, 丨 Jiu'an Medical (002432.SZ) announced that as of March 31, 2024, the company had repurchased a total of 19,376,561 shares through a special stock repurchase securities account, accounting for 3.96% of the company's total share capital. The highest transaction price was 41.277 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 783 million (not including transaction fees).
Subsidiary signs investment agreement with Dark Side of the Moon for 25 billion Kimi Concept Shares issued a change announcement|Highlights of post-market announcements
Zhongtai Chemical: The Securities Regulatory Commission decided to file a case against the controlling shareholder Zhongtai Group due to suspected illegal information disclosure
No Data